Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neumora Therapeutics, Inc. - Common Stock (NQ: NMRA ) 11.28 +0.29 (+2.64%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 490,573 Open 11.02 Bid (Size) 11.01 (1) Ask (Size) 11.95 (2) Prev. Close 10.99 Today's Range 10.75 - 11.31 52wk Range 8.330 - 21.00 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation June 20, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression May 14, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Performance YTD -33.25% -33.25% 1 Month +27.46% +27.46% 3 Month +8.36% +8.36% 6 Month -27.97% -27.97% 1 Year -30.58% -30.58% More News Read More NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q1 2024 May 07, 2024 Via InvestorPlace Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update May 07, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Neumora Therapeutics to Participate in Upcoming Conferences in May May 06, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March April 15, 2024 Via Benzinga Topics Stocks Exposures US Equities Crude Oil Down 1%; Charles Schwab Sales Top Estimates April 15, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday? April 15, 2024 Via Benzinga Exposures Product Safety Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 15, 2024 Via Benzinga Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug April 15, 2024 Via Investor's Business Daily Why Is Mobile Global Esports (MGAM) Stock Down 18% Today? April 15, 2024 Via InvestorPlace Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today? April 15, 2024 Via InvestorPlace Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session April 15, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Pre-Market Session April 15, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 15, 2024 Via InvestorPlace Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study April 15, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session March 13, 2024 Via Benzinga Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday March 13, 2024 Via Benzinga Topics Stocks Exposures US Equities Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days March 13, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 13, 2024 Via Benzinga NMRA Stock Earnings: Neumora Therapeutics Misses EPS for Q4 2023 March 07, 2024 Via InvestorPlace Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 07, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer January 22, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference January 02, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 22, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.